These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 31077090)

  • 1. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.
    Haghpanah V; Fallah P; Tavakoli R; Naderi M; Samimi H; Soleimani M; Larijani B
    Tumour Biol; 2016 Jan; 37(1):1299-308. PubMed ID: 26289851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
    J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
    Zhang L; Zhang J; Li S; Zhang Y; Liu Y; Dong J; Zhao W; Yu B; Wang H; Liu J
    RNA Biol; 2021 Apr; 18(4):547-562. PubMed ID: 32951513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis.
    Li Q; Dai Z; Xia C; Jin L; Chen X
    Mol Cell Biochem; 2020 Jul; 470(1-2):165-174. PubMed ID: 32468237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA H19 Influences Cellular Activities via the miR-454-3p/BHLHE40 Axis in Anaplastic Thyroid Carcinoma.
    Wu Y; Yang J; Zhang H; Cheng J; Lei P; Huang J
    Horm Metab Res; 2024 May; 56(5):392-399. PubMed ID: 38052232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
    Yan P; Su Z; Zhang Z; Gao T
    Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis.
    Sun R; Zhang L
    Biomed Pharmacother; 2019 Mar; 111():1036-1045. PubMed ID: 30841417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.
    Mio C; Conzatti K; Baldan F; Allegri L; Sponziello M; Rosignolo F; Russo D; Filetti S; Damante G
    Oncol Rep; 2018 Feb; 39(2):582-588. PubMed ID: 29251329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma.
    Xu B; Qin T; Yu J; Giordano TJ; Sartor MA; Koenig RJ
    J Biol Chem; 2020 Jun; 295(26):8834-8845. PubMed ID: 32398261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
    Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
    Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
    Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
    Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
    Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
    Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BI-847325, a selective dual MEK and Aurora kinases inhibitor, reduces aggressive behavior of anaplastic thyroid carcinoma on an in vitro three-dimensional culture.
    Samimi H; Tavakoli R; Fallah P; Naderi Sohi A; Amini Shirkouhi M; Naderi M; Haghpanah V
    Cancer Cell Int; 2022 Dec; 22(1):388. PubMed ID: 36482411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
    He L; Guo S; Zhu T; Chen C; Xu K
    Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
    Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
    Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-27b-3p is Involved in Doxorubicin Resistance of Human Anaplastic Thyroid Cancer Cells via Targeting Peroxisome Proliferator-Activated Receptor Gamma.
    Xu Y; Han YF; Ye B; Zhang YL; Dong JD; Zhu SJ; Chen J
    Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):670-677. PubMed ID: 29924913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA UCA1 promotes anaplastic thyroid cancer cell proliferation via miR‑135a‑mediated c‑myc activation.
    Wang Y; Hou Z; Li D
    Mol Med Rep; 2018 Sep; 18(3):3068-3076. PubMed ID: 30015867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.